Lanean...

Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma

B-cell non-Hodgkin lymphoma (B-NHL) is a group of heterogeneous disease which remains incurable despite developments of standard chemotherapy regimens and new therapeutic agents in decades. Some individuals could have promising response to standard therapy while others are unresponsive to standard c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomark Res
Egile Nagusiak: Yin, Zixun, Zhang, Ya, Wang, Xin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8278776/
https://ncbi.nlm.nih.gov/pubmed/34256851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00309-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!